Good Vigilance Practice

  • Japan
  • 医薬品、医薬部外品、化粧品、医療機器及び再生医療等製品の製造販売後安全管理の基準に関する省令
  • In Force
  • 2017-11-24
  • 2017-11-24
  • Ministry of Health, Labour and Welfare

This standard is based on the Pharmaceutical and Medical Devices Law of Japan Article 12, to manage post-sales safety for drugs, quasi-drugs, cosmetics and medical devices. 
 

The complete text of this article is only available to standard/corporate members.Click here to upgrade your membership or know the premium benefits.You are welcome to apply for a 14-day free trail to experience the benefits.